The new external drug for the treatment of psoriasis based on inhibition of serine proteases

The new external drug for the treatment of psoriasis based on inhibition of serine proteases

Background: Psoriasis is a chronic inflammatory immune-mediated disease characterized by an increased rate of keratinocyte division. The results of recent studies have made it possible to establish that the cytokines of the IL-36 family occupy a significant place in the initiation and regulation of...

Full description

Bibliographic Details
Main Authors: Alexander S. Zhukov, Evgeny R. Zharun, Vladislav R. Khairutdinov, Alexey V. Samtsov, Mihail Yu. Krasavin, A. V. Garabagiou
Format: Article
Language:English
Published: State Scientific Center of Dermatovenereology and Cosmetology 2021-07-01
Series:Vestnik Dermatologii i Venerologii
Subjects:
psoriasis
treatment
sivelestat
serine proteases
psoriasis model
il-36
Online Access:https://vestnikdv.ru/jour/article/viewFile/1219/1204

Internet

https://vestnikdv.ru/jour/article/viewFile/1219/1204

Similar Items